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Progeroid syndromes are a group of diseases char-
acterized by signs of premature aging. These syn-
dromes comprise diseases such as Werner syndrome,
Bloom syndrome, Rothmund–Thomson syndrome,
Hutchinson–Gilford syndrome, Fanconi anemia, and
ataxia–telangiectasia, as well as xeroderma pigmento-
sum, trichothiodystrophy, and Cockayne syndrome.
Clinical symptoms of premature aging are skin
atrophy with loss of cutaneous elasticity, dysfunction
of cutaneous appendices, degeneration of the central
nervous system and an increased susceptibility for
malignant tumors. Genetic defects in the repair of
DNA damage can lead to progeroid syndromes, and it
is becoming increasingly evident that direct DNA
damage and indirect damage by highly reactive
oxygen species play central roles in aging. The clinical
signs of progeroid syndromes and the molecular
aspects of UV (ultraviolet radiation)-induced oxidative
stress in aging are discussed.
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PROGEROID SYNDROMES
Progeroid syndromes are mostly monogenetic, rare, heredi-
tary diseases, characterized by the premature development of
signs and symptoms ordinarily associated with chronic aging.
As most of the progeroid syndromes usually show only a
limited number of features of premature aging, they are also
called syndromes of segmental progeria. Clinical hallmarks of
the progeroid syndromes include diabetes mellitus, changes
in the volume of adipose tissue, pigmentary changes with
hyper- and hypopigmentation of the skin (poikiloderma),
regional skin fibrosis, premature hair graying or hair loss,
osteoporosis, neurodegenerative symptoms, and tumors
typical of those seen in patients of older age.
Most progeroid syndromes include defects in
different DNA repair systems, such as nucleotide excision
repair (NER), base excision repair (BER), and double strand
break repair (DSBR). An increasing number of publications
indicate that the accumulation of DNA damage is an
important mediator of aging (Schumacher et al., 2008)
(Figure 1).
In this review, the clinical features of progeroid syndromes
will be discussed briefly, and subsequently the genotoxic
effects of UV radiation will be communicated. Furthermore,
as far as it is known, the underlying defects in DNA repair
systems are introduced with a focus on their susceptibility to
UV radiation-induced direct and indirect DNA damage in
relation to progeroid syndromes.
UV IRRADIATION AND OXIDATIVE STRESS
UV radiation is an important DNA stressor for skin cells. UVB
and UVC especially cause several types of DNA damage, of
which pyrimidine dimers (CPD) and 6-4 photoproducts are
the most prominent (Berneburg and Krutmann, 2000; de
Gruijl et al., 2001; Marrot and Meunier, 2008). Mutations
caused by unrepaired DNA damage can be deleterious to an
organism’s life functions, and the accumulation of mutations
during life is thought to be a cause of aging. The link between
impaired DNA repair and progeroid symptoms is under-
scored by the fact that patients with impaired NER also show
progeroid symptoms.
As the DNA absorption spectrum has its peak in the UVC
and UVB range, UVA radiation as a source of DNA damage
was long neglected. Although it was shown that UVA at high
doses would induce pyrimidine dimers (Rochette et al.,
2003), UVA primarily induces oxidative DNA lesions. DNA
damage from UVA can be mediated by reactive oxygen
species, primarily singlet oxygen, leading to the formation of
lesions such as tyminglycols, 8oxo-guanosine, and 8oxo-
adenosine. Nevertheless, there is an ongoing debate about
the contribution of UVA and UVA-induced DNA damage to
aging and carcinogenesis.
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WERNER SYNDROME
As early as 1904, Werner syndrome (WS) was described by
Otto Werner, on the basis of the premature development of
classical signs of aging (Kudlow et al., 2007). These include
scleroderma-like, atrophic skin, a loss of subcutaneous fat
tissue, ulceration of the skin, cataracts, premature graying,
and loss of hair, osteoporosis, atherosclerosis and diabetes
(Thweatt and Goldstein, 1993). The cancer risk in WS is also
elevated (Shibuya et al., 2005). Tumors include hematologi-
cal malignancies, as well as sarcomas and carcinomas of the
thyroid and other organs. WS patients develop signs of
accelerated aging after puberty, and they have a typical
appearance, together with thin arms and legs, a thick torso,
and a bird-like face. The incidence of this severe, recessive,
autosomal disease is 1 per million individuals. The causative
mutations are within the WRN gene on chromosome 8,
biochemically leading to truncation, destabilization, and loss
of the encoded WRN protein. In WS pathogenesis, two
important domains of the WRN gene must be deactivated: a
catalytically active 30-50 exonuclease and an ATPase-
helicase (belonging to the RecQ helicase family). Function-
ally, the WRN protein is involved in DNA replication,
homology-dependent recombination repair, and telomere
maintenance. Thus, dysfunctional or absent WRN protein
leads to defects in homologous recombination and, further-
more, to genomic instability, finally resulting in cell death.
The WRN protein is an important mediator in DNA DSBR.
DSBR can be divided into two subpathways: non-homo-
logous end joining and homologous recombination repair,
the latter requiring the presence of an identical template
strand.
Recently, it was shown that WRN protein oligomeres bind
to replication forks and Holliday junctions, which are
functionally important for homologous recombination
and replication at stalled or broken replication forks
(Compton et al., 2008). Additional functions in non-homo-
logous DNA-end joining, which is required not only for DNA
double-strand repair, but also for base-excision repair, have
been suspected (Hickson, 2003; Killoran and Keck, 2006).
The WRN protein may also play a role in BER, as
its interaction with BER proteins has been shown (Almeida
and Sobol, 2007).
In WS pathogenesis, error-prone repair processes, geno-
mic instability, and cell death caused by a dysfunctional or
absent WRN protein can lead to tissue dysfunction and
senescence, which may contribute to the aging phenotype.
Error-prone repair, increased mutation rates, and genomic
instability could contribute to increased susceptibility to
cancer, which is also observed in this disease (Multani and
Chang, 2007). However, the mechanistic role of WRN in
carcinogenesis is not certain. Up- or downregulation of WRN
protein levels has been found in different cancers. The WRN
protein, which seems to be expressed ubiquitously in normal
tissues, seems to be downregulated by epigenetic methylation
in some tumors such as colon carcinomas (Agrelo et al.,
2006), but upregulation of the WRN protein is also found in
cancer cells (Futami et al., 2008). In this context, it is
important to mention that although WRN levels can vary in
cancer patients with primarily functional WRN proteins, the
increased cancer incidence in WS patients is most likely
because of the accumulation of DNA mutations during its
pathogenesis.
BLOOM SYNDROME AND ROTHMUND–THOMSON
SYNDROME
Patients with Bloom syndrome are characterized by short
stature, skin photosensitivity, cafe´-au-lait macules, high-
pitched voice, narrow face, hypogonadism, and male
infertility, immunodeficiencies, chronic lung problems, and






























Figure 1. The role of DNA damage in carcinogenesis and aging. DNA damage caused by genotoxic events such as reactive oxygen species or UV radiation
induces DNA damage signaling systems, initiating DNA repair and regulating cell cycle checkpoints and apoptosis. The genome maintenance system, which
includes DNA damage signaling systems and DNA repair systems, is responsible for correct repair. If repair is erroneous, the fate of the affected cells can lead to
one of three different responses. If the damage is not compatible with life, apoptosis or necrosis is initiated. Otherwise, cells can initiate aging processes,
avoiding cell replication; or, if cell replication is maintained, it can lead to precancerous events.
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for many types of cancer, frequently for non-Hodgkin’s
lymphoma, leukemia, and skin cancer. Patients with
Rothmund–Thomson syndrome are of short stature, frequently
exhibiting skeletal abnormalities, saddle nose, telangiectasia,
juvenile cataracts, atrophic skin, hypo- and hyperpigmenta-
tion (poikiloderma), and alopecia. They also have an elevated
cancer predisposition, frequently experiencing not only
osteogenic sarcomas but also squamous- and basal-cell
carcinomas (Holman and Dyer, 2007). The Rothmund–Thom-
son syndrome is caused by defects in the RECQ4 helicase,
whereas the genetic cause of most of the patients with Bloom
syndrome is impairment of the BLM gene. The tumor-
suppressor genes BLM, RECQ4, and WRN belong to the
family of RecQ helicases, and they harbor a conserved
domain for a 30 to 50helicase, which unwinds DNA double
strands by hydrolyzing ATP. As with the WRN helicase, the
RECQ4 and the BLM helicases are necessary to maintain
genome integrity, but they differ in their functions and in their
interaction partners (Bachrati and Hickson, 2003; Killoran
and Keck, 2006). It is interesting that there is an interaction
among the tumor-suppressor proteins, FANCD2, BLM, and
ATM. Features of cells with defective BLM or RECQ4 genes
are abnormal DNA replication and high frequencies of
homologous recombination events. Functional RecQ heli-
cases may be involved in facilitating removal of mutations or
translesional synthesis during DNA replication.
Werner, Rothmund-Thomson, and Bloom syndromes
exhibit many distinct progeroid features, but all originate in
dysfunctional RecQ helicases. Their common feature is an
early-onset cancer predisposition, pointing to the clinical
importance of these tumor-suppressing helicases.
HUTCHINSON–GILFORD PROGERIA SYNDROME
(PROGERIA INFANTUM)
Hutchinson–Gilford progeria syndrome (HGPS) is one of the
most severe forms of progeria. Patients with HGPS develop
signs and symptoms during their first year of life, and their
mean life expectancy is 13 years, with stroke or coronary
failure as the main causes of death. Like WS, symptoms of
HGPS recapitulate many phenotypic signs of normal aging in
an accelerated form. Symptoms of HGPS are diffuse alopecia,
nail dystrophy, scleroderma-like skin changes with varied
skin hyperpigmentation, loss of subcutaneous fat tissue,
atherosclerosis, and rapid loss of joint mobility. There seems
to be no elevated risk for tumor formation, but this could be
attributed to the short life expectancy (Kudlow et al., 2007).
The genetic cause of this disease lies in mutations within
the LMNA gene. The gene encodes for A-type nuclear lamins,
such as lamin A and lamin C, which are encoded by
alternative splicing of the LMNA gene on chromosome 1.
They can multimerize into filaments, and they are the main
components of the nuclear lamina. Besides the function of
maintaining the integrity of the nuclear lamina, they are
thought to be involved in processes such as transcription,
replication, cell cycle control, and cellular differentiation.
Most patients with HGPS have a specific mutation in exon
11, leading to alternative splice sites at the 30 end of the
LMNA mRNA. This leads to truncation at the C terminal end
of lamin A, and the resulting protein is called progerin.
Progerin disrupts interactions of wild-type A and B lamins or
intercepts wild-type lamin A at the nuclear periphery. This
could explain the abnormal nuclear morphology of HGPS
cells (which is a reliable diagnostic marker for HGPS) and the
dominant inheritance of HGPS. It has also been shown in
murine models that an altered processing of Lamin A or
expression of progerin results in a more severe HGPS-like
phenotype than does deletion.
Although HGPS cells show increased p53 transcription
after DNA damage, these cells show delayed recruitment of
DNA repair proteins and sensitivity for DNA double-strand
breaks. It has been shown that expression of defective lamin
A hinders the formation of DNA repair foci after UV
irradiation or cisplatin treatment (Manju et al., 2006). The
manner in which progerin interferes with DNA repair
processes is still not known, but it would be interesting to
look for impaired NER, BER, and DSBR processes and
possible interaction of progerin with NER, BER, or DSBR
proteins. It was shown recently that expression of A-type
lamins in colorectal cancers increases the risk of death
because of increased invasiveness of these tumors (Willis
et al., 2008).
FANCONI ANEMIA
Patients with Fanconi anemia (FA) are of short stature, exhibit
skeletal and neurological anomalies during infancy, and have
an increased cancer risk (lymphoma, esophageal carcinoma
and head and neck squamous-cell carcinomas, liver, and
brain tumors), but mental defects and photosensitivity are not
observed (Figure 2). Commonly, FA is characterized by
infantile aplastic anemia, and many patients develop
malignancies such as acute myelogenous leukemia (Jacque-
mont and Taniguchi, 2007). Defects in several genes may
give rise to FA in an autosomal or X-linked recessive manner.
All of the FA genes are involved in a DNA damage-activated
Figure 2. 43-year-old female patient with Fanconi anemia and increased
chromosome instability with Mitomycin C. (a) Telangiectasia on the face and
(b) mild poikiloderma with hypo- and hyperpigmentation and three initial
squamous-cell carcinomas in the neck–chest region.
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signaling pathway, which is called the FA pathway. Cells
from FA patients are hypersensitive to DNA cross-linking
agents such as cisplatin, and they show accelerated telomere
shortening, which is because of increased telomere breakage
(Grillari et al., 2007). At present, 13 different complementa-
tion groups and 12 genes responsible for FA have been
identified, but little is known about the function of their
respective gene products. Eight FA proteins form a nuclear-
localized complex (FA core complex) with E3 ubiquitin ligase
enzymatic activity. This ligase activity catalyzes monoubi-
quitylation at lysine residues in target proteins. This mono-
ubiquitylation does not lead to proteasomal degradation, but
it can alter cellular localization or functions of the target
proteins. In response to DNA damage (primarily DNA
double-strand breaks) the FA core complex monoubiquity-
lates the FA protein, FANCD2, which later co-localizes to
DNA damage-associated nuclear foci, together with other
DNA repair proteins. As mentioned above, FA patients show
an increased risk for specific cancers, which points to the
important relationship between the FA pathway in genome
maintenance and carcinogenesis. It is of interest that in many
tumors (breast cancer, cervical cancer, non-small cell lung
cancer, testicular cancer, and head and neck squamous-cell
carcinomas) from non-FA patients, alterations in the FA
pathway have also been reported (Olopade and Wei, 2003;
Dhillon et al., 2004; Marsit et al., 2004; Narayan et al., 2004;
Wang et al., 2006). These cancers could have had their origin
in cancer predecessor cells, in which a hampered FA
pathway increased mutation rates.
ATAXIA–TELANGIECTASIA
Ataxia and telangiectasia (small dilated blood vessels near the
surface of the skin or mucous membranes) are the eponymous
signs of patients with ataxia–telangiectasia (A–T), also known
as Louis–Barr syndrome. A–T patients develop ataxia, with
problems in walking and standing beginning in childhood, so
that most patients are bound to wheelchairs by the age of ten.
A–T signs also include hypogonadism, progressive cerebellar
degeneration, immunodeficiency, and sensitivity to ionizing
radiation. Life expectancy is low because of a high incidence
of malignancies, such as leukemia, as well as immunodefi-
ciencies (Cimprich and Cortez, 2008). The genetic origin of
this disease is a defect in the ATM (Ataxia–Telangiectasia
Mutated) gene on chromosome 11. The ATM protein, a serine
threonine kinase, is an important interface between DNA
damage and activation of DNA repair mechanisms (Char-
ames and Bapat, 2003). Cells from A–T patients are
hypersensitive to DNA double-strand breaks (DSB), induced
by cisplatin or g-radiation, and it is well known that ATM is
involved in DSBR (Lee and Paull, 2007). Recently, it was
shown that ATM is also activated by UV or reactive oxygen
species treatment, leading to activation of p53 and check-
point kinases, but direct involvement in NER or BER
processes had not been suspected (Helt et al., 2005).
However, it was shown recently that ATM can influence
BER through post-translational modifications (Almeida and
Sobol, 2007). In meiosis, ATM is needed for recombination,
and in mitosis ATM is involved in activation of cell cycle
checkpoints in response to DNA damage. The latter function
can prevent chromosomal abnormalities and chromosomal
instability by stopping cell cycle progress until DNA damage
is repaired and thereby synchronize subsequent mitotic steps.
XERODERMA PIGMENTOSUM
The rare autosomal inherited progeroid diseases to be
discussed next all have defects in the NER system. Xeroderma
pigmentosum (XP) is characterized by extreme sun sensitivity,
and all patients are highly susceptible to development of
sunlight-induced cancers of the skin, with an approximate
1,000-fold increased risk (Figure 3). XP patients also have an
increased frequency of internal cancers, including central
nervous system cancers, and lung cancers (Berneburg et al.,
2000; Berneburg and Lehmann, 2001; Kraemer et al., 2007;
Lim et al., 2007). Other signs include skin telangiectasia,
ocular changes, and mental retardation. The genetic causes
of this severe disease are mutations in XP genes (XPA-XPG)
(de Laat et al., 1999; de Boer and Hoeijmakers, 2000),
leading to dysfunctional XP proteins. XP proteins are the
principal actors in the NER system (Maddukuri et al., 2007),
which will be outlined below.
Nucleotide excision repair is a versatile repair pathway
that removes bulky helix distorting DNA damage, such as
UVC- and UVB-induced CPD and 6-4 photoproducts, as well
as cisplatin. It has also been shown that NER is involved in
Figure 3. 22-year-old male patient with xeroderma pigmentosum.
Poikiloderma with hypo- and hyperpigmentation, paralleled by telangiectasia
and dry skin in sun-exposed areas. Ulcerated squamous-cell carcinoma on the
right side of nose.
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the removal of oxidative DNA damage. In this complex repair
process, a several base pair-long DNA single strand, which
harbors the mutation, is excised, and the gap is refilled by
DNA polymerase. The NER pathway can be divided into two
subpathways. The fast transcription-coupled repair (TCR)
pathway removes DNA damage from actively transcribed
genes, and the global genome repair (GGR) removes DNA
damage from the rest of the genome. For GGR damage,
recognition is carried out by the XPC protein in complex
with HR23B, whereas for TCR, damage is recognized by
stalled RNA polymerase. Subsequent steps of NER are similar
in both TCR and GGR. The XPA protein is necessary for
damage verification and recruitment of further NER factors,
XPB and XPD are helicases that unwind the DNA on both
sides of the damaged area. In subsequent steps, XPE and XPF
endonucleases excise the DNA single-strand harboring the
mutation. Finally, after the DNA polymerase refills the gap,
and after ligation, the damaged DNA is repaired.
Cells of XP patients show defects in NER, affecting TCR or
GGR or both. In XP, deficiency in the repair of direct UV-
induced DNA damage may explain the photosensitivity and
the increased skin cancer risk. In contrast, Cockayne
syndrome, described below, also includes defective repair
of indirect oxidative DNA damage, which may account for its
stronger progeroid phenotype.
TRICHOTHIODYSTROPHY
Clinical signs of trichothiodystrophy (TTD) include charac-
teristic brittle hair and nails. More severe signs are
neurological and skeletal degeneration, marked photosensi-
tivity, growth, and mental retardation, as well as ichthyosis.
In contrast to XP, patients with TTD do not have an increased
risk for skin cancer, although the causative mutations can
reside in the same gene (Lim et al., 2007). There are three
different complementation groups for TTD. The majority of
patients harbor mutations in the XPD gene, in which XPD or
TTD or XP in combination with Cockayne syndrome (CS) can
occur (Berneburg and Lehmann, 2001; Kraemer et al., 2007).
The second group has mutations in the XPB gene. The third
group shows a temperature sensitive instability of the
transcription factor TFIIH.
COCKAYNE SYNDROME
Cockayne syndrome is characterized by mental and devel-
opmental retardation and photosensitivity. Other signs are
progressive sensorineural hearing loss, short stature, a typical
bird-like face, deep-set eyes, loss of subcutaneous fat, and
progressive neurological degeneration. Patients show signs of
progressive aging and suffer from progressive neurodegenera-
tion, with demyelinization of the brain stem and cerebellum
(Berneburg and Lehmann, 2001). There are two complemen-
tation groups in CS: CSA and CSB, but specific mutations in
the XPB-, XPD- and XPG-genes can also cause a CS
phenotype (Berneburg et al., 2000; Berneburg and Lehmann,
2001; Kraemer et al., 2007; Lim et al., 2007). Cells from CS
patients are characterized by impaired TCR. Unlike XP cells,
which also can have defects in the TCR subpathway, the
cancer incidence in CS patients is not elevated. This
observation seems to be counterintuitive, as one would
expect that accumulating dysfunctional NER mutations
would increase cancer susceptibility. Although this argument
would seem to be conclusive, differences between XP and CS
could be explained by the additional functions of CSA and
CSB proteins. It was shown that CSB also plays a role in basal
transcription, as it can be found in complex with RNA
polymerase II. CS cells show generally lower transcription
rates compared with CS-proficient cells, and it has been
hypothesized that transcription defects could cause the
neurodegenerative features of CS (Kraemer et al., 2007).
There is also increasing evidence that CSA and CSB proteins
are involved in the repair of oxidative DNA damage, either in
the BER system or in newly recognized repair systems
(Frosina, 2008; Stevnsner et al., 2008). In BER, a single
damaged nucleotide is removed by specific enzyme com-
plexes. The removal of 8oxo-guanosine (8oxoG), in which
the glycosylase 8-oxoguanosineglycosylase removes the
damaged 8oxoG from its ribose backbone, leaving an abasic
site in the DNA, is well characterized (Sung and Demple,
2006). In this repair process, the ribose at the abasic site is
removed, and the missing nucleotide is refilled by a specific
polymerase.
BER and NER systems are generally believed to operate
separately, with each system specific for different types of
UV-induced DNA damage. But recent work documents the
involvement of specific proteins in the NER system during
removal of oxidative lesions specific for the BER system
(Frosina, 2008; Stevnsner et al., 2008). This is especially
certain for CSA and CSB proteins, which are involved in the
TCR NER subpathway (Dianov et al., 1999; Tuo et al., 2003;
D’Errico et al., 2007; Trapp et al., 2007; Wong et al., 2007). It
was shown that human fibroblasts of CSA- and CSB-deficient
cells are also defective in the repair of 8oxoG and
8oxo-adenine (Tuo et al., 2003; D’Errico et al., 2007).
In addition, Tuo et al. (2003) have shown that depletion of
CSB proteins decreases the rate of BER-dependent repair of
8 oxoG, further indicating that BER-specific hOgg (human
8-oxoGuanosineglycosylase) and CSB might act as a com-
mon protein complex. Furthermore, Wong et al.
(2007) showed that BER-associated apurinic/apyrimidinic
endonuclease (APE1) interacts with the CSB protein. In
Ogg1-deficient mice, repair of 8oxoG is impaired (Arai
et al., 2002), as CSB-deficient mice show age-dependent
accumulation of 8oxoG and other oxidative DNA lesions.
However, in mice deficient in Ogg1 and CSB, 8oxoG
accumulation is much higher, strengthening the link between
BER-associated Ogg1 and NER-associated CSB protein. Not
only do TCR-associated NER proteins such as CSA and CSB
seem to have additional functions in the repair of oxidative
DNA damage but so also does the GGR-associated NER
protein XPC, as has been shown in the work of Kassam and
Rainbow (2007).
Therefore, as described above, the discovery of new roles
for the CS proteins in other repair pathways, such as the
repair of oxidative stress, may help to differentiate among the
pathways that lead to either carcinogenesis on the one hand
or aging on the other.
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CONCLUSION
Progeroid syndromes are a heterogeneous group of diseases
with overlapping features of accelerated aging. Problems in
genome maintenance caused by impairment in the function
of different genes are responsible for the clinical features of
these diseases. Owing to mutations in these genes, important
functions of genome maintenance, including repair systems,
such as DSBR, NER, and BER as well as DNA damage
signaling, are impaired. Cancer predisposition and early
onset of aging are clinical features of most of the progeroid
syndromes, but the highly increased frequency of skin cancer
in the NER-deficient disease, XP, points to the importance of
this repair system for UV-induced skin cancer. On the other
hand, NER-deficient diseases such as CS and TTD do not
show increased photocarcinogenesis. There is increasing
evidence that the different systems of genome maintenance
are linked to each other and that DNA repair proteins play
multifunctional roles in different repair systems. Interplay of
NER systems with other repair systems such as BER is
becoming increasingly important in clarifying the roles of
specific genes in genome maintenance and the contrast
between aging and carcinogenesis.
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